Anita Deswal
Department Chair
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (24)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Aims Radiation therapy (RT) is an integral component of cancer therapy but associated with adverse events. Our goal was to establish risk prediction models for major adverse cardiovascular and cerebrovascular events (MACCE) after chest RT. Methods and results A retrospective study of lung/breast cancer patients who had chest RT with planning CT at Mayo Clinic between 01/2010 and 01/2014. Predictive models were developed based on weighted independent predictors using a derivation (406 lung and 711 breast cancer) and validation cohort (179 lung and 234 breast cancer). Patient characteristics, pre-RT CT for coronary artery calcification (CAC), and post-RT MACCE data were reviewed. Post-RT MACCE occurred in 6.1 and 5.6% in the derivation and validation cohort over a mean follow-up of 42 ± 13 months. Post-therapy model (C2AD2) included CAC (two points), MACCE history (two points), age ≥74 (three points), DM (two points), and mean heart radiation dose ≥ 850 mGy (two points), and pre-therapy model (C2AD) included post-therapy model parameters minus mean heart radiation dose. Both models stratified patients into three risk groups: low (0–2), intermediate (3–5), and high (≥6). Post-RT MACCE across these groups were 2.7, 8.9, and 19.8% in the derivation, and 3.9, 6.6, and 16.4% in the validation cohort for post-therapy model (C2AD2) and 2.8, 9.2, and 20.4% in the derivation and 3.7, 9.2, and 13.2% in the validation cohort for pre-therapy model. Both models showed statistically significant graded survival outcome. Conclusion Post-therapy (C2AD2) and pre-therapy (C2AD) models are simple, easy to use and effective tools to stratify breast and lung cancer patients undergoing chest radiation for post-RT MACCE.
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Collaborators (35)
Amit Pursnani
-
Paul S. Brookes
Professor
University of Rochester
Raul Cordoba
Hospital Universitario Fundación Jiménez Díaz
Cezar Iliescu
Professor of Medicine, Interventional Cardiology
The University of Texas MD Anderson Cancer Center
Wei-Ting Chang
Associate Prof
National Sun Yat-Sen University
Keri Schadler
Associate Professor
The University of Texas MD Anderson Cancer Center
Meenakshi Bhattacharjee
Professor & Director of Neuropathology
The University of Texas Health Science Center at Houston
Han Zhu
Stanford University School of Medicine
Avirup Guha
Director of Cardio-Oncology
Augusta University
Iqbal Mahmud
Assistant Professor
Lamar University
Efstratios Koutroumpakis
Assistant Professor
The University of Texas MD Anderson Cancer Center
Louis Maximilian Buja
Professor
The University of Texas Health Science Center at Houston
Nordin M.J. Hanssen
Amsterdam University Medical Centers
Lorenz Lehmann
Head of Cardio-Oncology Unit
University Hospital Heidelberg
Saadia Faiz
Professor
The University of Texas MD Anderson Cancer Center
John Cooke
Professor and Department Chair
Houston Methodist Research Institute
Guangyu Wang
Assistant Professor
Houston Methodist
James P. Allison
Professor and Chair
The University of Texas MD Anderson Cancer Center
Yibo Dai
The University of Texas MD Anderson Cancer Center
Arjun K Ghosh
University College London Hospitals NHS Foundation Trust
Ying H. Shen
Baylor College of Medicine
Wendong Yu
Professor
The University of Texas MD Anderson Cancer Center
Jun-ichi Abe
The University of Texas MD Anderson Cancer Center
Teresa López-Fernández
La Paz University Hospital
Sreyashi Basu
The University of Texas MD Anderson Cancer Center
Nicolas Palaskas
Assistant Professor
The University of Texas MD Anderson Cancer Center
Sumit Subudhi
Assistant Professor
The University of Texas MD Anderson Cancer Center
sivareddy kotla
Assistant Professor
The University of Texas MD Anderson Cancer Center
Jinzhong Yang
The University of Texas MD Anderson Cancer Center
James F. Martin
Professor
Baylor College of Medicine
Kirk Roberts
Associate Professor
The University of Texas Health Science Center at Houston
Linghua Wang
Executive Director & Head
The University of Texas MD Anderson Cancer Center
Jared Burks
Professor
The University of Texas MD Anderson Cancer Center
Sandeep Sahay
Associate Professor
Texas A&M University
Erin Seeley
Mass Spectrometry Imaging Facility Director
University of Texas at Austin
Make your next move.
Prepare your application
Review drafts before you send them.